A comprehensive view of Journal of the American Medical Association JAMA. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
Obesity patients regain weight after quitting Eli Lilly's drug Zepbound, suggests a study published in the Journal of the American Medical Assn., study finds patients lost an average of 20.9% of body weight while on drug, regained 14% after stopping drug
Published:
December 11, 2023
by Proactive Investors
|
Peer-reviewed study finds Pfizer's danuglipron oral weight loss drug proves as effective as Novo Nordisk's Ozempic injection in clinical trial; Pfizer drug offers a potentially more convenient treatment option: JAMA Network
Published:
May 23, 2023
by Baystreet US News Alerts
|
Ask us about our Consumer Wellness market view